Figure 4.
One-way sensitivity analysis of incremental cost per quality-adjust life year (QALYs) as function of A) prevalence, B) test sensitivity, C) test specificity, D) cost of screening test and E) cost of confirmation and diagnostic testing; and F) the ratio of cost of BMTlate vs. BMTearly (cost BMTlate/cost BMTearly).